Found 112 matching trials
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults PHASE1 To assess the safety and immune response to two experimental vaccines when ...
Show More Learn More & Join Trial
Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults PHASE1 The purpose of the study is to evaluate the safety, tolerability, and immun...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml NA To provide product through an expanded access program to HIV-infected patie...
Show More Location
Immune Response Corp
Learn More & Join Trial
Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes PHASE1 Our research is part of the global effort to develop a vaccine against HIV....
Show More Location
Imperial College London
Learn More & Join Trial
Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV PHASE2 The purpose of this study is to see whether or not an HIV vaccination will ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines PHASE1 The purpose of this study is to see if it is safe and effective to give AID...
Show More Location
Dr Frank Judson / Director of Public Health Dept
Learn More & Join Trial
An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater. NA To provide an alternative therapy to HIV-infected patients for whom there i...
Show More Location
Immune Response Corp
Learn More & Join Trial
A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection PHASE4 This study assessed the safety and tolerability of enfuvirtide in participa...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults PHASE1 This is a double blind, randomized, placebo-controlled, parallel design, st...
Show More Location
University of North Carolina at Chapel Hill
Learn More & Join Trial
Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens PHASE1 The objective of this experimental medicine study is to determine the exten...
Show More Location
NIHR Imperial Clinical Resarch Facility
Learn More & Join Trial